Receptor tyrosine kinases in normal and malignant haematopoiesis (Q35558528)

8 August 2017

1 reference

title

Receptor tyrosine kinases in normal and malignant haematopoiesis (English)

1 reference

8 August 2017

0 references

1 reference

https://api.crossref.org/works/10.1016/S0268-960X(03)00024-9

20 March 2024

author name string

John T. Reilly

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14556779

20 March 2024

language of work or name

1 reference

1 December 2003

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S0268960X03000249?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0268-960X(03)00024-9

https://api.elsevier.com/content/article/PII:S0268960X03000249?httpAccept=text/plain

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0268-960X(03)00024-9

20 March 2024

1 reference

8 August 2017

volume

17

1 reference

8 August 2017

issue

4

1 reference

8 August 2017

page(s)

241-248

1 reference

Oncogenic kinase signalling

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

The protein kinase complement of the human genome

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

The protein tyrosine kinase family of the human genome

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Receptor tyrosine kinase mutations in myeloid neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Loss of imprinting of human insulin-like growth factor II gene, IGF2, in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

cDNA cloning and expression of the human A-type platelet-derived growth factor (PDGF) receptor establishes structural similarity to the B-type PDGF receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Early signaling pathways activated by c-Kit in hematopoietic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Activating c-kit gene mutations in human germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Substitution of an aspartic acid results in constitutive activation of c-kit receptor tyrosine kinase in a rat tumor mast cell line RBL-2H3

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

c-kit proto-oncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

C-Kit point mutations in core binding factor leukemias: correlation with white blood cell count and the white blood cell index

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

FLT3 and its Role in the Pathogenesis of Acute Myeloid Leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the Unite

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA)

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Constitutive activation of FLT3 in acute myeloid leukaemia and its consequences for growth of 32D cells

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Identification of novel FLT-3 Asp835 mutations in adult acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Myeloproliferative disorders with translocations of chromosome 5q31-35: role of the platelet-derived growth factor receptor Beta

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Novel translocations that disrupt the platelet-derived growth factor receptor beta (PDGFRB) gene in BCR-ABL-negative chronic myeloproliferative disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

The t(4;22)(q12;q11) in atypical chronic myeloid leukaemia fuses BCR to PDGFRA.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

t(6;8), t(8;9) and t(8;13) translocations associated with stem cell myeloproliferative disorders have close or identical breakpoints in chromosome region 8p11-12

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Analysis of FGFR3 gene mutations in multiple myeloma patients with t(4;14)

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

The myeloma-associated oncogene fibroblast growth factor receptor 3 is transforming in hematopoietic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Role of vascular endothelial growth factor (VEGF) and placenta-derived growth factor (PlGF) in regulating human haemopoietic cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Clinical relevance of vascular endothelial growth factor receptors 1 and 2 in acute myeloid leukaemia and myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Insights into the molecular pathogenesis and targeted treatment of lymphedema

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Expression of neurotrophins and their receptors in human bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Identification and characterization of an activating TrkA deletion mutation in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

High expression of the receptor tyrosine kinase Tie-1 in acute myeloid leukemia and myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Expression of angiopoietin-1 and its receptor TEK in hematopoietic cells from patients with myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

The fusion gene Cbfb-MYH11 blocks myeloid differentiation and predisposes mice to acute myelomonocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Heterozygous PU.1 mutations are associated with acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

The AML1-ETO fusion protein promotes the expansion of human hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Constitutive activation of c-kit by the juxtamembrane but not the catalytic domain mutations is inhibited selectively by tyrosine kinase inhibitors STI571 and AG1296.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Sustained complete hematologic remission after administration of the tyrosine kinase inhibitor imatinib mesylate in a patient with refractory, secondary AML.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Protein tyrosine phosphatase containing SH2 domains: characterization, preferential expression in hematopoietic cells, and localization to human chromosome 12p12-p13.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Regulation of colony-stimulating factor 1 receptor signaling by the SH2 domain-containing tyrosine phosphatase SHPTP1

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Signalling by the W/Kit receptor tyrosine kinase is negatively regulated in vivo by the protein tyrosine phosphatase Shp1

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Lack of phosphotyrosine phosphatase SHP-1 expression in malignant T-cell lymphoma cells results from methylation of the SHP-1 promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Regulation of constitutive STAT5 phosphorylation in acute myeloid leukemia blasts.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

RTK mutations and human syndromeswhen good receptors turn bad.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900024-9

7 January 2021

A new myeloproliferative disorder associated with chromosomal translocations involving 8p11: a review

series ordinal

44

1 reference

https://api.crossref.org/works/10.1016/S0268-960X(03)00024-9

Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation

20 March 2024

series ordinal

55

1 reference

https://api.crossref.org/works/10.1016/S0268-960X(03)00024-9

20 March 2024

Identifiers

1 reference

8 August 2017

1 reference